Maxcyte (MXCT) Finished Goods (2020 - 2026)

Maxcyte (MXCT) has 7 years of Finished Goods data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Finished Goods fell 3.08% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 3.08% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 18.97% from the prior year.
• Finished Goods for Q1 2026 stood at $3.5 million, up from $3.2 million in the prior quarter.
• Over the last five years, Finished Goods for MXCT reached as high as $6.0 million in Q1 2024 and fell as low as $2.7 million in Q3 2022.
• Historically, Finished Goods has averaged $4.0 million across 5 years, with a median of $3.5 million in 2023.
• Across the five-year window, Finished Goods jumped 121.46% in 2023 and tumbled 40.19% in 2025, its largest moves.
• Year by year, Finished Goods stood at $2.9 million in 2022, then soared by 103.99% to $6.0 million in 2023, then slumped by 34.3% to $3.9 million in 2024, then dropped by 18.97% to $3.2 million in 2025, then grew by 9.87% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Finished Goods figures were $3.5 million in Q1 2026, $3.2 million in Q4 2025, and $3.3 million in Q3 2025.